Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial
2011 · Drug and Alcohol Dependence · 217 citations
https://doi.org/10.1016/j.drugalcdep.2010.12.010
D
Daniel J. Brooks
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
142
Papers
5.0K
Citations
37
h-index
82
i10-index
Daniel J. Brooks is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Bone Metabolism and Diseases & Bone health and treatments & Attention Deficit Hyperactivity Disorder. The author has an h-index of 37, co-authored 121 publications.
ORCID: 0000-0001-7408-9851Papers by this author
worksSIKs control osteocyte responses to parathyroid hormone
2016 · Nature Communications · 159 citations
https://doi.org/10.1038/ncomms13176
Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial
2015 · Drug and Alcohol Dependence · 104 citations
https://doi.org/10.1016/j.drugalcdep.2015.11.025
Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin
2021 · Nature Communications · 94 citations
https://doi.org/10.1038/s41467-021-26571-7
A randomized double‐blind, placebo‐controlled trial of venlafaxine‐extended release for co‐occurring cannabis dependence and depressive disorders
2013 · Addiction · 86 citations
https://doi.org/10.1111/add.12108
A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
2020 · Nature Communications · 85 citations
https://doi.org/10.1038/s41467-020-17099-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat